What's in Human Genome Sciences Inc., a GSK Company's pipeline?

Human Genome Sciences Inc., a GSK Company has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Human Genome Sciences Inc., a GSK Company's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Nanjing University School of Medicine, National University Hospital, Singapore.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/human-genome-sciences-inc-a-gsk-company.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Human Genome Sciences Inc., a GSK Company — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Human Genome Sciences Inc., a GSK Company pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Belimumab plus Late Vaccination	Belimumab plus Late Vaccination	marketed
Belimumab plus Early Vaccination	Belimumab plus Early Vaccination	marketed	BLyS inhibitor monoclonal antibody	B-lymphocyte stimulator (BLyS)	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 1 shared drug class
Nanjing University School of Medicine · 1 shared drug class
National University Hospital, Singapore · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Human Genome Sciences Inc., a GSK Company:

Cite this brief

Drug Landscape (2026). Human Genome Sciences Inc., a GSK Company — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/human-genome-sciences-inc-a-gsk-company. Accessed 2026-05-17.